Alexandra Balcom
Chief Financial Officer; Director · 7 filings · Latest: Jul 15, 2026
CRESCENT BIOPHARMA, INC.
Nuvalent, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
NUVL | Alexandra Balcom | Chief Financial Officer | Jul 1, 2026 | Sale | $123.58 | 11,430 | $1.4M | 85,533 | |
NUVL | Alexandra Balcom | Chief Financial Officer | Jul 1, 2026 | Option Exercise | $13.26 | 11,430 | $151.5K | 96,963 | |
NUVL | Alexandra Balcom | — | Jul 1, 2026 | Proposed Sale | $123.53 | 22,860 | $2.8M | — | |
NUVL | Alexandra Balcom | Chief Financial Officer | Jun 1, 2026 | Sale | $98.69 | 11,430 | $1.1M | 85,533 | |
NUVL | Alexandra Balcom | Chief Financial Officer | Jun 1, 2026 | Option Exercise | $6.89 | 11,430 | $78.8K | 96,963 | |
NUVL | Alexandra Balcom | Chief Financial Officer | May 1, 2026 | Sale | $99.00 | 11,430 | $1.1M | 85,533 | |
NUVL | Alexandra Balcom | Chief Financial Officer | May 1, 2026 | Option Exercise | $3.25 | 11,430 | $37.2K | 96,963 | |
NUVL | Alexandra Balcom | Chief Financial Officer | Apr 1, 2026 | Sale | $105.21 | 11,430 | $1.2M | 85,533 | |
NUVL | Alexandra Balcom | Chief Financial Officer | Apr 1, 2026 | Option Exercise | $1.08 | 11,430 | $12.3K | 96,963 | |
NUVL | Alexandra Balcom | Chief Financial Officer | Mar 25, 2026 | Sale | $100.16 | 13,700 | $1.4M | 85,533 | |
NUVL | Alexandra Balcom | Chief Financial Officer | Mar 24, 2026 | Sale | $95.75 | 11,430 | $1.1M | 99,233 | |
NUVL | Alexandra Balcom | Chief Financial Officer | Mar 24, 2026 | Option Exercise | $1.08 | 11,430 | $12.3K | 110,663 | |
NUVL | Alexandra Balcom | — | Mar 24, 2026 | Proposed Sale | $96.43 | 59,420 | $5.7M | — | |
NUVL | Alexandra Balcom | — | Jan 6, 2026 | Proposed Sale | $97.58 | 7,417 | $723.8K | — | |
NUVL | Alexandra Balcom | — | Dec 8, 2025 | Proposed Sale | $109.60 | 7,084 | $776.4K | — | |
NUVL | Alexandra Balcom | — | Nov 17, 2025 | Proposed Sale | $93.72 | 13,854 | $1.3M | — | |
NUVL | Alexandra Balcom | — | Oct 13, 2025 | Proposed Sale | $89.32 | 48,558 | $4.3M | — | |
NUVL | Alexandra Balcom | — | Sep 29, 2025 | Proposed Sale | $81.30 | 60,000 | $4.9M | — | |
NUVL | Alexandra Balcom | — | Jun 27, 2025 | Proposed Sale | $80.00 | 129,480 | $10.4M | — | |
NUVL | Alexandra Balcom | — | Jan 6, 2025 | Proposed Sale | $80.78 | 4,250 | $343.3K | — |
Page 1 of 2
Next →